← Back to Search

Behavioural Intervention

3D Kidney Model Education for Kidney Disease

N/A
Waitlist Available
Research Sponsored by Hilary L Surratt, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 18 and older
Current diagnosis of hypertension and renal disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post intervention, approximately 1 hour
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to evaluate a new patient education tool (3D-printed models of healthy and diseased kidneys) to improve education for underserved populations at risk for hypertension-induced chronic kidney disease. High

Who is the study for?
This trial is for individuals from minoritized communities with high blood pressure that may lead to chronic kidney disease. It aims to educate those who might not have extensive knowledge about the impact of hypertension on kidneys, focusing on African American and Hispanic populations affected by health disparities.
What is being tested?
The study is testing a new patient education tool: 3D-printed models of healthy and diseased kidneys. Participants will receive standard medical treatment for high blood pressure and kidney issues, plus education using these models to see if it improves understanding and management of their condition.
What are the potential side effects?
Since this trial focuses on education rather than medication or invasive procedures, there are no direct side effects from the intervention itself. However, participants' emotional or psychological responses to learning about their health conditions in detail could vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have high blood pressure and kidney disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post intervention, approximately 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post intervention, approximately 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in participant confidence for kidney disease management

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 3D Kidney model enhanced patient educationExperimental Treatment1 Intervention
patient education with 3D model
Group II: Standard clinical care/TAUActive Control1 Intervention
standard clinician-led patient education

Find a Location

Who is running the clinical trial?

University of KentuckyOTHER
194 Previous Clinical Trials
223,625 Total Patients Enrolled
Hilary L Surratt, PhDLead Sponsor
2 Previous Clinical Trials
504 Total Patients Enrolled
~67 spots leftby Jul 2025